Pharmacologic inhibitors of PI3K/Akt potentiate the apoptotic action of the antileukemic drug arsenic trioxide via glutathione depletion and increased peroxide accumulation in myeloid leukemia cells
- PMID: 15665116
- DOI: 10.1182/blood-2004-07-2802
Pharmacologic inhibitors of PI3K/Akt potentiate the apoptotic action of the antileukemic drug arsenic trioxide via glutathione depletion and increased peroxide accumulation in myeloid leukemia cells
Abstract
Treatment for 14 to 24 hours with low concentrations of arsenic trioxide (As2O3, 1-4 microM) caused apoptosis in U-937 promonocytes and other human myeloid leukemia cell lines (HL-60, NB4). This effect was potentiated by cotreatment with the phosphatidylinositol 3-kinase (PI3K) inhibitors LY294002 and wortmannin, and the Akt inhibitor Akt(i)5. However, the inhibitors did not increase the toxicity of the mitochondria-targeting drug lonidamine, and the DNA-specific drugs camptothecin and cisplatin, when used under similar experimental conditions as As2O3. The potentiation of As2O3-provoked apoptosis involved the increased disruption of mitochondrial transmembrane potential, increased caspase-3 activation and cytochrome c release from mitochondria, increased Bax and Bid activation, and attenuation of 27-kDa heat shock protein (HSP27) expression; the potentiation was prevented by Bcl-2 overexpression. The PI3K/Akt inhibitors decreased the intracellular glutathione content, and caused intracellular oxidation, as measured by peroxide accumulation. Cotreatment with subcytotoxic concentrations of hydrogen peroxide increased apoptosis induction by As2O3. On the other hand, the treatments did not significantly affect glutathione S-transferase pi expression and activity. These results, which indicate that glutathione is a target of PI3K/Akt in myeloid leukemia cells, may partially explain the selective increase of As2O3 toxicity by PI3K/Akt inhibitors, and may provide a rationale to improve the efficacy of these inhibitors as therapeutic agents.
Similar articles
-
Curcumin stimulates reactive oxygen species production and potentiates apoptosis induction by the antitumor drugs arsenic trioxide and lonidamine in human myeloid leukemia cell lines.J Pharmacol Exp Ther. 2010 Oct;335(1):114-23. doi: 10.1124/jpet.110.168344. Epub 2010 Jul 6. J Pharmacol Exp Ther. 2010. PMID: 20605902
-
Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells.J Cell Physiol. 2005 Feb;202(2):623-34. doi: 10.1002/jcp.20153. J Cell Physiol. 2005. PMID: 15316930
-
Pharmacologic inhibitors of extracellular signal-regulated kinase (ERKs) and c-Jun NH(2)-terminal kinase (JNK) decrease glutathione content and sensitize human promonocytic leukemia cells to arsenic trioxide-induced apoptosis.J Cell Physiol. 2006 Dec;209(3):1006-15. doi: 10.1002/jcp.20806. J Cell Physiol. 2006. PMID: 16972261
-
Arsenic-induced apoptosis in malignant cells in vitro.Leuk Lymphoma. 2000 Mar;37(1-2):53-63. doi: 10.3109/10428190009057628. Leuk Lymphoma. 2000. PMID: 10721769 Review.
-
Arsenic trioxide: acute promyelocytic leukemia and beyond.Leuk Lymphoma. 2002 Aug;43(8):1535-40. doi: 10.1080/1042819021000002857. Leuk Lymphoma. 2002. PMID: 12400595 Review.
Cited by
-
Small molecule sensitization to TRAIL is mediated via nuclear localization, phosphorylation and inhibition of chaperone activity of Hsp27.Cell Death Dis. 2013 Oct 31;4(10):e890. doi: 10.1038/cddis.2013.413. Cell Death Dis. 2013. PMID: 24176848 Free PMC article.
-
Therapeutic Potential of Arsenic Trioxide (ATO) in Treatment of Hepatocellular Carcinoma: Role of Oxidative Stress in ATO-Induced Apoptosis.Ann Clin Pathol. 2017;5(1):1101. Epub 2017 Jan 4. Ann Clin Pathol. 2017. PMID: 29214213 Free PMC article.
-
Downregulation of Mcl-1 through GSK-3β activation contributes to arsenic trioxide-induced apoptosis in acute myeloid leukemia cells.Leukemia. 2013 Feb;27(2):315-24. doi: 10.1038/leu.2012.180. Epub 2012 Jul 3. Leukemia. 2013. PMID: 22751450 Free PMC article.
-
Arsenic trioxide induces autophagy and apoptosis in human glioma cells in vitro and in vivo through downregulation of survivin.J Mol Med (Berl). 2011 Sep;89(9):927-41. doi: 10.1007/s00109-011-0763-1. Epub 2011 May 19. J Mol Med (Berl). 2011. PMID: 21594580
-
p75NTR-dependent modulation of cellular handling of reactive oxygen species.J Neurochem. 2009 Jul;110(1):295-306. doi: 10.1111/j.1471-4159.2009.06137.x. Epub 2009 Apr 30. J Neurochem. 2009. PMID: 19457114 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous